Cargando…
Cytochrome P450 CYP1B1 activity in renal cell carcinoma
Renal cell carcinoma (RCC) is the most common malignancy of the kidney and has a poor prognosis due to its late presentation and resistance to current anticancer drugs. One mechanism of drug resistance, which is potentially amenable to therapeutic intervention, is based on studies in our laboratory....
Autores principales: | McFadyen, M C E, Melvin, W T, Murray, G I |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409861/ https://www.ncbi.nlm.nih.gov/pubmed/15280921 http://dx.doi.org/10.1038/sj.bjc.6602053 |
Ejemplares similares
-
Cytochrome P450 CYP3A in human renal cell cancer
por: Murray, G I, et al.
Publicado: (1999) -
Cytochrome P450 CYP1B1 over-expression in primary and metastatic ovarian cancer
por: McFadyen, M C E, et al.
Publicado: (2001) -
Analysis of the cytochrome c-dependent apoptosis apparatus in cells from human pancreatic carcinoma
por: Gerhard, M C, et al.
Publicado: (2002) -
Expression of cyclin D1, D3, E, and p27 in human renal cell carcinoma analysed by tissue microarray
por: Hedberg, Y, et al.
Publicado: (2003) -
Prediction of progression in pTa and pT1 bladder carcinomas with p53, p16 and pRb
por: Hitchings, A W, et al.
Publicado: (2004)